Sirio Pharma Co., Ltd. (SHE:300791)

Sirio Pharma Revenue

Sirio Pharma had revenue of 1.09B CNY in the quarter ending June 30, 2025, with 4.66% growth. This brings the company's revenue in the last twelve months to 4.26B, up 5.82% year-over-year. In the year 2024, Sirio Pharma had annual revenue of 4.21B with 17.56% growth.

• Revenue (ttm): 4.26B
• Revenue Growth: +5.82%
• P/S Ratio: 1.72
• Revenue / Employee: 1.54M
• Employees: 2,776
• Market Cap: 7.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.21B	629.04M	17.56%
Dec 31, 2023	3.58B	1.07B	42.87%
Jan 1, 2023	2.51B	138.31M	5.84%
Dec 31, 2021	2.37B	302.13M	14.62%
Dec 31, 2020	2.07B	487.26M	30.85%